Winconsortium: Transcriptomic Algorithm Shows Ability to Predict Progression-Free Survival in Cancer Patients
WIN Consortium researchers have shown that a prototype "digital display precision predictor" may identify patents who will live longer on treatments without progression.
Read full article »
CEO
Winconsortium is a Private company. Winconsortium generates $85.8K in revenue per employee Winconsortium has 2 followers on Owler.